Shanghai BaojuBPC-157
Ordered BPC-157 from Shanghai Baoju? Mail in a sample (US only) and let us test it for free.
Test my supplyShanghai Baoju's BPC-157 evidence is mixed: identity and fill stayed acceptable, but purity includes a 91.19% early miss and a later 99.3% miss. Later batch IDs and a 99.9% recent result improve the trajectory.
Supplier-platform records and domain archives conflict with the claimed company history. The report maps UK WhatsApp channels, Telegram personas, and a Henan Zhitai/ZZTaiTech trail that complicates accountability.
Unlock original COAs
View and download original lab PDFs for Finnrick tests, including Shanghai Baoju rows.
Cancel anytime
About Shanghai Baoju test results from Finnrick
Shanghai Baoju is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 9 peptides and 101 tests, including ratings, observed price signals, recent test dates, and correction history where available.
Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.
The most visible Shanghai Baoju peptides in this dataset are BPC-157 (6 tests), Cagrilintide (5 tests) and GHK-Cu (12 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.
Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 101 recent tests.
Ordered BPC-157 from Shanghai Baoju? Mail in a sample (US only) and let us test it for free.
Test my supply